Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-23-022636

President and CEO sold 5,510 shares at an average $0.65 ($3,576)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lucchino David L. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-08-14 Sale : show line 1 in the form 10b5-1 −2,881 $0.63 $1,815 647,923 D
2023-08-15 Sale : show line 2 in the form 10b5-1 −2,629 $0.67 $1,761 645,294 D
Open-market sales · 5,510 sh · avg $0.65 · $3,576
Loading xslF345X05/form4.xml…